Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R; RISCAVID Study Group. Panichi V, et al. Among authors: bigazzi r. Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27. Nephrol Dial Transplant. 2008. PMID: 18305316
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G, Panichi V, Paoletti S, Grassi D, Bigazzi R, Beati S, Bernabini G, Rosati A, Ferri C, Taddei S, Ghiadoni L; RISCAVID investigators. Desideri G, et al. Among authors: bigazzi r. Nephrol Dial Transplant. 2011 Sep;26(9):2983-8. doi: 10.1093/ndt/gfq823. Epub 2011 Feb 8. Nephrol Dial Transplant. 2011. PMID: 21303961
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.
Panichi V, Rosati A, Bigazzi R, Paoletti S, Mantuano E, Beati S, Marchetti V, Bernabini G, Grazi G, Rizza GM, Migliori M, Giusti R, Lippi A, Casani A, Barsotti G, Tetta C; RISCAVID Study Group. Panichi V, et al. Among authors: bigazzi r. Nephrol Dial Transplant. 2011 Aug;26(8):2641-8. doi: 10.1093/ndt/gfq802. Epub 2011 Feb 16. Nephrol Dial Transplant. 2011. PMID: 21325348
A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, Bernabini G, Daini R, Casani A, Angelini D, Parrini M, Rossi A, Petrone I, Barsotti G, Donadio C, Donati G, Grazi G, Manca Rizza G, Garosi G, Sansoni E, Braccagni B, Sidoti A, Boracelli D, Biagioli M, Moriconi L, Finato V, Mannarino A, Grimaldi C, Pansa F, Imperiali P, Mura C, Bianchi S, Bigazzi R. Panichi V, et al. Among authors: bigazzi r. Blood Purif. 2011;32(1):7-14. doi: 10.1159/000321369. Epub 2011 Jan 14. Blood Purif. 2011. PMID: 21242686 Clinical Trial.
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.
Canaud B, Mingardi G, Braun J, Aljama P, Kerr PG, Locatelli F, Villa G, Van Vlem B, McMahon AW, Kerloëguen C, Beyer U; STRIATA Study Investigators. Canaud B, et al. Nephrol Dial Transplant. 2008 Nov;23(11):3654-61. doi: 10.1093/ndt/gfn320. Epub 2008 Jun 27. Nephrol Dial Transplant. 2008. PMID: 18586762 Free PMC article. Clinical Trial.
Microalbuminuria in essential hypertension.
Bianchi S, Bigazzi R, Campese VM. Bianchi S, et al. Among authors: bigazzi r. J Nephrol. 1997 Jul-Aug;10(4):216-9. J Nephrol. 1997. PMID: 9377730 Review.
68 results